Rhabdomyolysis as a rare severe complication of statin therapy: differential diagnosis in real clinical practice (a clinical case)

The mechanisms of drug-induced myopathies include direct myotoxicity, immune-mediated and indirect muscle damage. Clinical manifestations range from asymptomatic or minor myalgia and muscle weakness to chronic myopathy with severe weakness and, in rare cases, rhabdomyolysis with release of cellular...

Descripció completa

Dades bibliogràfiques

Autors principals:	A. V. Melekhov, S. V. Borisovskaya, N. S. Gavrilina, I. I. Gaponova, I. G. Nikitin, O. A. Ettinger
Format:	Artigo
Idioma:	Inglês
Publicat:	Столичная издательская компания 2025-06-01
Col·lecció:	Рациональная фармакотерапия в кардиологии
Matèries:	lipids statins high-intensity statin therapy statin intolerance statin-associated muscle symptoms drug induced myopathy statin-induced myopathy rhabdomyolysis acute renal injury
Accés en línia:	https://www.rpcardio.online/jour/article/view/3110
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!